Celyad Oncology
Provider of cell therapy treatments with an initial focus on cardiology and oncology,.
HQ location
Mont-Saint-Guibert, Belgium
Website
Launch date
Employees
Market cap
$16.5m
Enterprise value
$3m
Share price
$0.52 CYAD
Company register number
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | €9.8m | Private Placement VC | |
| Total Funding | 000k | ||
SRIW(exited)
Hunza Ventures(exited)
Grifols(exited)
Mayo Clinic Ventures(exited)
Fortress Investment Group(exited)
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (25 %) | 233 % | 580 % | - | - | - | 82 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (1033 %) | (290 %) | (38 %) | - | - | (8827 %) | (3058 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (1233 %) | (290 %) | (25 %) | - | - | (8282 %) | (3131 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Celyad Oncology
Edit
ACQUISITION by Celyad Oncology Nov 2014